Accordingly, the improvement of antioxidative defense mechanisms and attenuation of the inflammatory response by targeting the Nrf2 and Nf-κB pathways hold great potential for slowing down the vicious cycle of molecular and cellular changes that result in hippocampal damage and cognitive decline. The gene discussed is NFKB1; the disease is Mental deterioration.